The purpose of the study is to compare the potential of HbA1c to diagnose diabetes among Palestinian Arabs compared to fasting plasma glucose (FPG). A cross-sectional sample of 1370 Palestinian men (468) and women (902) without known diabetes and above the age of 30 years were recruited. Whole blood was used to estimate HbA1c and plasma for FPG and total lipid profile. Fasting plasma glucose was used as a reference to diagnose diabetes (≥ 126 mg/dL) and prediabetes (100–125 mg/dL). The area under the receiver operating characteristic curve (AUC) for HbA1c was 81.9% to diagnose diabetes and 63.9% for prediabetes. The agreement between HbA1c and diabetes as diagnosed by FPG was moderate (？ = 0.498) and low with prediabetes (？ = 0.142). The optimal cut-off value for HbA1c to diagnose diabetes was ≥ 6.3% (45 mmol/mol). The sensitivity, specificity and the discriminant ability were 65.6% (53.1–76.3%), 94.5% (93.1–95.6%), 80.0% (72.8–87.3%), respectively. However, using cut-off value of ≥ 6.5% (48 mmol/mol) improved specificity. At this cut-off value, the sensitivity, specificity and the discriminant ability were 57.4% (44.9–69.0%), 97.1% (96.0–97.9%) and 77.3% (71.0–83.5%). For diagnosing prediabetes with HbA1c between 5.7–6.4% (39–46 mmol/mol), the sensitivity, specificity and the discriminant ability were 62.7% (57.1–67.9%), 56.3% (53.1–59.4%) and 59.5% (56.3–62.5%), respectively. HbA1c at cut-off value of ≥ 6.5% (48 mmol/mol) by itself diagnosed 5.3% and 48.3% as having diabetes and prediabetes compared to 4.5% and 24.2% using FPG, respectively. Mean HbA1c and FPG increase significantly with increasing body mass index. In conclusion, the ROC curves showed HbA1c could be used for diagnosing diabetes when compared to FPG but not for prediabetes in Palestinians Arabs even though only about 50% of the diabetic subjects were identified by the both HbA1c and FPG.
References
[1]
Cavagnolli G, Gross JL, Camargo JL (2012) HbA1c in the diagnosis of diabetes: which cut-off point? Diabet Med 29: 286–287. doi: 10.1111/j.1464-5491.2011.03397.x
[2]
Hare MJ, Shaw JE, Zimmet PZ (2012) Current controversies in the use of haemoglobin A1c. J Intern Med 271: 227–236. doi: 10.1111/j.1365-2796.2012.02513.x
[3]
International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 32: 1327–1334. doi: 10.2337/dc09-9033
[4]
Association AD (2010) Standards of medical care in diabetes—2010. Diabetes Care 33 Suppl 1S11–61. doi: 10.2337/dc10-s011
[5]
Sacks DB, Arnold M, Bakris GL, Bruns DE, Horvath AR, et al. (2011) Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 57: e1–e47. doi: 10.1373/clinchem.2010.161596
[6]
WHO (2011) Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus: Abbreviated Report of a WHO Consultant.
[7]
Shaw JE, d'Emden MC, Goodall I (2011) Is Australia ready to use glycated haemoglobin for the diagnosis of diabetes? Med J Aust 195: 7–8. doi: 10.5694/mja11.10920
[8]
Davidson MB (2011) Diagnosing diabetes with glucose criteria: worshiping a false God. Diabetes Care 34: 524–526. doi: 10.2337/dc10-1689
[9]
Day A (2012) HbA1c and diagnosis of diabetes. The test has finally come of age. Ann Clin Biochem 49: 7–8. doi: 10.1258/acb.2011.011255
[10]
Malkani S, Mordes JP (2011) Implications of using hemoglobin A1C for diagnosing diabetes mellitus. Am J Med 124: 395–401. doi: 10.1016/j.amjmed.2010.11.025
[11]
Sacks DB (2011) A1C versus glucose testing: a comparison. Diabetes Care 34: 518–523. doi: 10.2337/dc10-1546
[12]
Cheng YJ, Gregg EW, Geiss LS, Imperatore G, Williams DE, et al. (2009) Association of A1C and fasting plasma glucose levels with diabetic retinopathy prevalence in the U.S. population: Implications for diabetes diagnostic thresholds. Diabetes Care 32: 2027–2032. doi: 10.2337/dc09-0440
[13]
Dagogo-Jack S (2010) Pitfalls in the use of HbA(1)(c) as a diagnostic test: the ethnic conundrum. Nat Rev Endocrinol 6: 589–593. doi: 10.1038/nrendo.2010.126
[14]
Ma H, Gao X, Lin HD, Hu Y, Li XM, et al. (2013) Glycated Haemoglobin in Diagnosis of Diabetes Mellitus and Pre-diabetes among Middle-aged and Elderly Population: Shanghai Changfeng Study. Biomed Environ Sci 26: 155–162.
[15]
Mukai N, Doi Y, Ninomiya T, Hata J, Hirakawa Y, et al. (2012) Cut-off values of fasting and post-load plasma glucose and HbA1c for predicting Type 2 diabetes in community-dwelling Japanese subjects: the Hisayama Study. Diabet Med 29: 99–106. doi: 10.1111/j.1464-5491.2011.03378.x
[16]
Tsugawa Y, Takahashi O, Meigs JB, Davis RB, Imamura F, et al. (2012) New diabetes diagnostic threshold of hemoglobin A(1c) and the 3-year incidence of retinopathy. Diabetes 61: 3280–3284. doi: 10.2337/db12-0103
[17]
Lu ZX, Walker KZ, O'Dea K, Sikaris KA, Shaw JE (2010) A1C for screening and diagnosis of type 2 diabetes in routine clinical practice. Diabetes Care 33: 817–819. doi: 10.2337/dc09-1763
[18]
Bernal-Lopez MR, Santamaria-Fernandez S, Lopez-Carmona D, Tinahones FJ, Mancera-Romero J, et al. (2011) HbA(1c) in adults without known diabetes from southern Europe. Impact of the new diagnostic criteria in clinical practice. Diabet Med 28: 1319–1322. doi: 10.1111/j.1464-5491.2011.03317.x
[19]
Jorgensen ME, Bjerregaard P, Borch-Johnsen K, Witte D (2010) New diagnostic criteria for diabetes: is the change from glucose to HbA1c possible in all populations? J Clin Endocrinol Metab 95: E333–336. doi: 10.1210/jc.2010-0710
[20]
Kramer CK, Araneta MR, Barrett-Connor E (2010) A1C and diabetes diagnosis: The Rancho Bernardo Study. Diabetes Care 33: 101–103. doi: 10.2337/dc09-1366
[21]
Rathmann W, Kowall B, Tamayo T, Giani G, Holle R, et al. (2012) Hemoglobin A1c and glucose criteria identify different subjects as having type 2 diabetes in middle-aged and older populations: the KORA S4/F4 Study. Ann Med 44: 170–177. doi: 10.3109/07853890.2010.531759
[22]
Soulimane S, Simon D, Shaw JE, Zimmet PZ, Vol S, et al. (2011) Comparing incident diabetes as defined by fasting plasma glucose or by HbA(1c). The AusDiab, Inter99 and DESIR studies. Diabet Med 28: 1311–1318. doi: 10.1111/j.1464-5491.2011.03403.x
[23]
Kawada T (2012) Is there any ethnic difference in the prevalence of prediabetes? Am J Clin Pathol 137: 500–501. doi: 10.1309/ajcponil38uyshrh
[24]
Pinelli NR, Jantz AS, Martin ET, Jaber LA (2011) Sensitivity and specificity of glycated hemoglobin as a diagnostic test for diabetes and prediabetes in Arabs. J Clin Endocrinol Metab 96: E1680–1683. doi: 10.1210/jc.2011-1148
[25]
Hajat C, Harrison O, Al Siksek Z (2011) Diagnostic testing for diabetes using HbA(1c) in the Abu Dhabi population: Weqaya: the Abu Dhabi cardiovascular screening program. Diabetes Care 34: 2400–2402. doi: 10.2337/dc11-0284
[26]
Malik M, Bakir A, Saab BA, King H (2005) Glucose intolerance and associated factors in the multi-ethnic population of the United Arab Emirates: results of a national survey. Diabetes Res Clin Pract 69: 188–195. doi: 10.1016/j.diabres.2005.11.001
[27]
Cavagnolli G, Comerlato J, Comerlato C, Renz PB, Gross JL, et al. (2011) HbA(1c) measurement for the diagnosis of diabetes: is it enough? Diabet Med 28: 31–35. doi: 10.1111/j.1464-5491.2010.03159.x
[28]
Hayes L, Hawthorne G, Unwin N (2012) Undiagnosed diabetes in the over-60s: performance of the Association of Public Health Observatories (APHO) Diabetes Prevalence Model in a general practice. Diabet Med 29: 115–120. doi: 10.1111/j.1464-5491.2011.03389.x
[29]
Costa B, Barrio F, Pinol JL, Cabre JJ, Mundet X, et al. (2013) Shifting from glucose diagnosis to the new HbA1c diagnosis reduces the capability of the Finnish Diabetes Risk Score (FINDRISC) to screen for glucose abnormalities within a real-life primary healthcare preventive strategy. BMC Med 11: 45. doi: 10.1186/1741-7015-11-45
[30]
Lipska KJ, De Rekeneire N, Van Ness PH, Johnson KC, Kanaya A, et al. (2010) Identifying dysglycemic states in older adults: implications of the emerging use of hemoglobin A1c. J Clin Endocrinol Metab 95: 5289–5295. doi: 10.1210/jc.2010-1171
[31]
Miranda JJ, Bernabe-Ortiz A, Stanojevic S, Malaga G, Gilman RH, et al. (2011) A1C as a diagnostic criteria for diabetes in low- and middle-income settings: evidence from Peru. PLoS One 6: e18069. doi: 10.1371/journal.pone.0018069
[32]
Bersoux S, Cook CB, Wu Q, Burritt MF, Hernandez JS, et al. (2011) Hemoglobin A1c testing alone does not sufficiently identify patients with prediabetes. Am J Clin Pathol 135: 674–677. doi: 10.1309/ajcpjbg0wyrahn0r
[33]
Seo HA, Lee IK (2012) An emerging diabetes mellitus diagnosis modality: HbA(1c). Korean J Intern Med 27: 39–40. doi: 10.3904/kjim.2012.27.1.39
[34]
Rohlfing CL, Little RR, Wiedmeyer HM, England JD, Madsen R, et al. (2000) Use of GHb (HbA1c) in screening for undiagnosed diabetes in the U.S. population. Diabetes Care 23: 187–191. doi: 10.2337/diacare.23.2.187
[35]
Yu Y, Ouyang XJ, Lou QL, Gu LB, Mo YZ, et al. (2012) Validity of glycated hemoglobin in screening and diagnosing type 2 diabetes mellitus in Chinese subjects. Korean J Intern Med 27: 41–46. doi: 10.3904/kjim.2012.27.1.41
[36]
Tatsch E, Bochi GV, Piva SJ, Pereira RS, Kober H, et al. (2012) Hba(1c) as a tool for the diagnosis of type 2 diabetes: comparison with fasting glucose. Clin Lab 58: 347–350.
